{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:01:11Z","timestamp":1791489671552,"version":"4.3.4"},"reference-count":365,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":261,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101454","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:17:34Z","timestamp":1789993054000},"page":"101454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Multi-omics and molecular biomarkers in breast cancer: a comprehensive review of diagnostic, prognostic, and predictive applications"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5651-1555","authenticated-orcid":false,"given":"Kamyar","family":"Bagheri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0325-8662","authenticated-orcid":false,"given":"Amirhossein","family":"Saberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5200-1499","authenticated-orcid":false,"given":"Maryam","family":"Zand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1864-4766","authenticated-orcid":false,"given":"Ali","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"09","key":"10.1016\/j.ctarc.2026.101454_bib0001","doi-asserted-by":"crossref","first-page":"422","DOI":"10.52533\/JOHS.2024.40911","article-title":"Preventive strategies and screening protocols for early detection of breast cancer","volume":"04","author":"Balobaid","year":"2024","journal-title":"J. Healthcare Sci."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0002","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101454_bib0003","first-page":"287","article-title":"Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN","volume":"5","author":"Zhang","year":"2025","journal-title":"J. Natl. Cancer Cent."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0004","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s40364-024-00631-8","article-title":"Global burden of breast cancer and attributable risk factors in 204 countries and territories, from 1990 to 2021: results from the Global Burden of Disease Study 2021","volume":"12","author":"Sha","year":"2024","journal-title":"Biomark. Res."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0005","doi-asserted-by":"crossref","first-page":"9347","DOI":"10.1038\/s41598-025-93883-9","article-title":"The global burden of breast cancer among women of reproductive age: a comprehensive analysis","volume":"15","author":"Cai","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0006","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41597-023-02253-5","article-title":"Global trends and forecasts of breast cancer incidence and deaths","volume":"10","author":"Xu","year":"2023","journal-title":"Sci. Data"},{"key":"10.1016\/j.ctarc.2026.101454_bib0007","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1200\/OP.2024.20.10_suppl.146","article-title":"The global and regional disease burden of breast cancer from 1980 to 2021: an analysis of GBD study 2021","volume":"20","author":"Ahmad","year":"2024","journal-title":"JCo Oncol. Pract."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0008","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1067\/j.cpradiol.2024.10.036","article-title":"Breast imaging: what women & healthcare professionals need to know","volume":"54","author":"Seely","year":"2025","journal-title":"Curr. Probl. Diagn. Radiol."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101454_bib0009","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3390\/cancers16071326","article-title":"Lead-time corrected effect on breast cancer survival in Germany by mode of detection","volume":"16","author":"Schumann","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0010","article-title":"Awareness and early detection of breast cancer","volume":"2","author":"Misbah","year":"2025","journal-title":"J. Med. Health Sci. Rev."},{"key":"10.1016\/j.ctarc.2026.101454_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.120030","article-title":"An overview about biomarkers in breast cancer: insights into the diagnostic and prognostic significance","volume":"567","author":"Emanuelle Pereira Santos","year":"2025","journal-title":"Clin. Chim. Acta"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101454_bib0012","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1007\/s12094-024-03454-z","article-title":"Exploring research progress in studying serum exosomal miRNA-21 as a molecular diagnostic marker for breast cancer","volume":"26","author":"Li","year":"2024","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.ctarc.2026.101454_bib0013","article-title":"Protein biomarkers for diagnosis of breast cancer","volume":"25","author":"Iweala","year":"2024","journal-title":"Sci. Afr."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101454_bib0014","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1007\/s12094-024-03541-1","article-title":"Biomarkers in breast cancer 2024: an updated consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology","volume":"26","author":"Colomer","year":"2024","journal-title":"Clin. Transl. Oncol."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101454_bib0015","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMra0801289","article-title":"Gene-expression signatures in breast cancer","volume":"360","author":"Sotiriou","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ctarc.2026.101454_bib0016","doi-asserted-by":"crossref","first-page":"vi7","DOI":"10.1093\/annonc\/mdt284","article-title":"Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Senkus","year":"2013","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101454_bib0017","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41571-023-00849-9","article-title":"Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives","volume":"21","author":"Marra","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101454_bib0018","doi-asserted-by":"crossref","first-page":"9688","DOI":"10.3390\/ijms24119688","article-title":"Next-generation sequencing and triple-negative breast cancer: insights and applications","volume":"24","author":"Tierno","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0019","article-title":"The role of multi-omics in breast cancer diagnosis and research","volume":"22","author":"Kulczynska-Figurny","year":"2025","journal-title":"Lett. Oncol. Sci."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101454_bib0020","doi-asserted-by":"crossref","first-page":"491","DOI":"10.14740\/jocmr5237","article-title":"The effects of preoperative serum carcinoembryonic antigen, cancer antigen 15-3 and cancer antigen 125 on the prognosis of breast cancer patients with different molecular subtypes","volume":"16","author":"Yilihamu","year":"2024","journal-title":"J. Clin. Med. Res."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0021","article-title":"The influence of tumor-specific markers in breast cancer on other blood parameters","volume":"14","author":"Varzaru","year":"2024","journal-title":"Life (Basel)"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101454_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2025.109688","article-title":"Assessing the diagnostic value of oncological biomarkers for identifying primary malignancies in skeletal metastatic disease","volume":"51","author":"Matilainen","year":"2025","journal-title":"Eur. J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101454_bib0023","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3892\/ol.2025.14879","article-title":"Clinical utility of quantitative ultrasonography parameters combined with serum cancer antigen 15\u20113, human epidermal growth factor receptor 2 and soluble E\u2011cadherin in diagnosing mass\u2011type breast cancer","volume":"29","author":"Hu","year":"2025","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ctarc.2026.101454_bib0024","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/14737159.2025.2482639","article-title":"Multi-omic profiling in breast cancer: utility for advancing diagnostics and clinical care","volume":"25","author":"Gazzah","year":"2025","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"10.1016\/j.ctarc.2026.101454_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1292046","article-title":"Multiomics insights on the onset, progression, and metastatic evolution of breast cancer","volume":"13","author":"Alvarez-Frutos","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctarc.2026.101454_bib0026","article-title":"Editorial: diagnosis and treatment of breast cancer in 2022: the rise of novel molecular biomarkers","volume":"9","author":"Fusco","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0027","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1186\/s12967-025-06495-2","article-title":"DNA methylation in breast cancer: early detection and biomarker discovery through current and emerging approaches","volume":"23","author":"Hum","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ctarc.2026.101454_bib0028","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-3-031-70875-6_13","article-title":"Molecular basis of breast tumor heterogeneity","volume":"1464","author":"Dikoglu","year":"2025","journal-title":"Adv. Exp. Med. Biol."},{"issue":"8050","key":"10.1016\/j.ctarc.2026.101454_bib0029","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s41586-024-08377-x","article-title":"Complex rearrangements fuel ER+ and HER2+ breast tumours","volume":"638","author":"Houlahan","year":"2025","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101454_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17030441","article-title":"Heterogeneity in Cancer","volume":"17","author":"MacDonald","year":"2025","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0031","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40164-022-00363-1","article-title":"Breast cancer heterogeneity and its implication in personalized precision therapy","volume":"12","author":"Guo","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.ctarc.2026.101454_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1170264","article-title":"The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneity","volume":"13","author":"Salemme","year":"2023","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101454_bib0033","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.62347\/MWNZ5609","article-title":"Advancing precision and personalized breast cancer treatment through multi-omics technologies","volume":"14","author":"Zhang","year":"2024","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101454_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1087432","article-title":"Delineating intra-tumoral heterogeneity and tumor evolution in breast cancer using precision-based approaches","volume":"14","author":"Xulu","year":"2023","journal-title":"Front. Genet."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101454_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167120","article-title":"Multi-OMICS approaches in cancer biology: new era in cancer therapy","volume":"1870","author":"Chakraborty","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Basis. Dis."},{"key":"10.1016\/j.ctarc.2026.101454_bib0036","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5604\/01.3001.0054.8093","article-title":"Multifaceted landscape ofOmics data","volume":"20","author":"Mudadla","year":"2024","journal-title":"Bio-Algorith. Med-Syst."},{"key":"10.1016\/j.ctarc.2026.101454_bib0037","article-title":"Editorial: multi-omics approaches in the study of human disease mechanisms","volume":"4","author":"Wang","year":"2024","journal-title":"Front. Bioinform."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101454_bib0038","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70331","article-title":"Unravelling tumour spatiotemporal heterogeneity using spatial multimodal data","volume":"15","author":"Zuo","year":"2025","journal-title":"Clin. Transl. Med."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101454_bib0039","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1245\/s10434-024-15449-9","article-title":"Multi-omic analysis: a possible platform toward personalized and adaptable cancer treatment","volume":"31","author":"Benesch","year":"2024","journal-title":"Ann. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0040","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/proteomes11040034","article-title":"Multi-omics integration for the design of novel therapies and the identification of novel biomarkers","volume":"11","author":"Ivanisevic","year":"2023","journal-title":"Proteomes"},{"key":"10.1016\/j.ctarc.2026.101454_bib0041","article-title":"Integrative Multi-Omics approaches for personalized medicine and health","volume":"20","author":"Tiwari","year":"2025","journal-title":"Curr. Bioinform."},{"key":"10.1016\/j.ctarc.2026.101454_bib0042","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.783494","article-title":"Breast cancer resistance likelihood and personalized treatment through integrated multiomics","volume":"9","author":"Mehmood","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"Suppl 2(6)","key":"10.1016\/j.ctarc.2026.101454_bib0043","first-page":"104","article-title":"Omics sciences and precision medicine in breast and ovarian cancer","volume":"174","author":"Bonetti","year":"2023","journal-title":"Clin. Ter."},{"key":"10.1016\/j.ctarc.2026.101454_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2025.103892","article-title":"Multimodal data integration in early-stage breast cancer","volume":"80","author":"Llinas-Bertran","year":"2025","journal-title":"The Breast"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0045","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae300","article-title":"Advancing drug-response prediction using multi-modal and -omics machine learning integration (MOMLIN): a case study on breast cancer clinical data","volume":"25","author":"Rashid","year":"2024","journal-title":"Brief. Bioinform."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0046","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41523-025-00750-x","article-title":"MammOnc-DB, an integrative breast cancer data analysis platform for target discovery","volume":"11","author":"Karthikeyan","year":"2025","journal-title":"NPJ. Breast. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0047","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1186\/s12967-025-06662-5","article-title":"Comparative analysis of statistical and deep learning-based multi-omics integration for breast cancer subtype classification","volume":"23","author":"Omran","year":"2025","journal-title":"J. Transl. Med."},{"issue":"16","key":"10.1016\/j.ctarc.2026.101454_bib0048","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612690","article-title":"Omics technologies improving breast cancer research and diagnostics","volume":"24","author":"Orsini","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101454_bib0049","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.3390\/biomedicines12122750","article-title":"Revolutionizing personalized medicine: synergy with Multi-Omics data generation, main hurdles, and future perspectives","volume":"12","author":"Molla","year":"2024","journal-title":"Biomedicines"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101454_bib0050","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.arcmed.2022.11.003","article-title":"Cancer epigenetics: an overview","volume":"53","author":"Recillas-Targa","year":"2022","journal-title":"Arch. Med. Res."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0051","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41420-024-01803-z","article-title":"Cancer epigenetics: from laboratory studies and clinical trials to precision medicine","volume":"10","author":"Yu","year":"2024","journal-title":"Cell Death. Discov."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101454_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2025.101268","article-title":"The role of genetics and epigenetics in breast cancer: a comprehensive review of metastasis, risk factors, and future perspectives","volume":"15","author":"Chai","year":"2025","journal-title":"J. Pharm. Anal."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101454_bib0053","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s12282-024-01628-9","article-title":"Applying whole-genome and whole-exome sequencing in breast cancer: a review of the landscape","volume":"31","author":"Ganatra","year":"2024","journal-title":"Breast. Cancer"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101454_bib0054","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/s41588-023-01466-z","article-title":"Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk","volume":"55","author":"Wilcox","year":"2023","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101454_bib0055","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.annonc.2025.01.021","article-title":"Whole genome sequencing-powered ctDNA sequencing for breast cancer detection","volume":"36","author":"Garcia-Murillas","year":"2025","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0056","article-title":"Somatic mutational landscape across Indian breast cancer cases by whole exome sequencing","volume":"14","author":"Kumar","year":"2024","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100452","article-title":"Whole-genome sequencing analysis of male breast cancer unveils novel structural events and potential therapeutic targets","volume":"37","author":"Al Assaad","year":"2024","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0058","doi-asserted-by":"crossref","DOI":"10.1080\/15592294.2025.2539995","article-title":"Advancements in DNA methylation technologies and their application in cancer diagnosis","volume":"20","author":"Yang","year":"2025","journal-title":"Epigenetics"},{"key":"10.1016\/j.ctarc.2026.101454_bib0059","first-page":"227","article-title":"Evaluation of DNA methylation of MAP9 gene in breast cancer as epigenetic biomarker","volume":"42","author":"Rasheed","year":"2022","journal-title":"Biomedicine (Taipei)"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12957-021-02124-6","article-title":"Identification of differentially methylated genes as diagnostic and prognostic biomarkers of breast cancer","volume":"19","author":"Mao","year":"2021","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.ctarc.2026.101454_bib0061","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergen.2023.12.003","article-title":"Methylation signatures as biomarkers for non-invasive early detection of breast cancer: a systematic review of the literature","volume":"282-283","author":"Gonzalez","year":"2024","journal-title":"Cancer Genet."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0062","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13148-024-01674-2","article-title":"Machine learning unveils an immune-related DNA methylation profile in germline DNA from breast cancer patients","volume":"16","author":"Lee","year":"2024","journal-title":"Clin. Epigenetics."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0063","doi-asserted-by":"crossref","DOI":"10.52225\/narra.v5i1.1364","article-title":"DNA methylation profiles for breast cancer subtype classifications: a translational study from microarray to methylation-specific PCR (MSP)","volume":"5","author":"Panigoro","year":"2025","journal-title":"Narra J"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0064","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13058-024-01955-x","article-title":"Tumour DNA methylation markers associated with breast cancer survival: a replication study","volume":"27","author":"Zarean","year":"2025","journal-title":"Breast. Cancer Res."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0065","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13058-025-02004-x","article-title":"DNA methylation-predicted plasma protein levels and breast cancer risk","volume":"27","author":"Kresovich","year":"2025","journal-title":"Breast. Cancer Res."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101454_bib0066","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1002\/2211-5463.13211","article-title":"Prognostic biomarker identification and tumor classification in breast cancer patients by methylation and transcriptome analysis","volume":"11","author":"Zhong","year":"2021","journal-title":"FEBS. Open. Bio"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101454_bib0067","doi-asserted-by":"crossref","first-page":"683","DOI":"10.21037\/atm-21-1128","article-title":"Methylated biomarkers for breast cancer identified through public database analysis and plasma target capture sequencing","volume":"9","author":"Luo","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ctarc.2026.101454_bib0068","doi-asserted-by":"crossref","DOI":"10.1016\/j.bspc.2023.104979","article-title":"XAI-CNVMarker: explainable AI-based copy number variant biomarker discovery for breast cancer subtypes","volume":"84","author":"Rajpal","year":"2023","journal-title":"Biomed. Signal. Process. Control"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101454_bib0069","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3390\/cells12071086","article-title":"Copy number variation in inflammatory breast cancer","volume":"12","author":"Hazra","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ctarc.2026.101454_bib0070","article-title":"Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data","volume":"13","author":"Zhao","year":"2022","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101454_bib0071","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3390\/ijms26020770","article-title":"Immunohistochemical profiling of histone modification biomarkers identifies subtype-specific epigenetic signatures and potential drug targets in breast cancer","volume":"26","author":"Huo","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2026.101454_bib0072","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1328679","article-title":"Lactylproteome analysis indicates histone H4K12 lactylation as a novel biomarker in triple-negative breast cancer","volume":"15","author":"Cui","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0073","doi-asserted-by":"crossref","first-page":"8205","DOI":"10.1038\/s41598-025-92666-6","article-title":"Appraising histone H4 lysine 5 lactylation as a novel biomarker in breast cancer","volume":"15","author":"Zhu","year":"2025","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101454_bib0074","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00428-023-03534-5","article-title":"Survival is associated with repressive histone trimethylation markers in both HR-positive HER2-negative and triple-negative breast cancer patients","volume":"482","author":"Wang","year":"2023","journal-title":"Virchows Arch."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0075","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3390\/cells14040307","article-title":"The emerging role of the histone H2AK13\/15 ubiquitination: mechanisms of writing, reading, and erasing in DNA damage repair and disease","volume":"14","author":"Shu","year":"2025","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0076","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41420-025-02334-x","article-title":"Anaerobic metabolism promotes breast cancer survival via histone-3 lysine-18 lactylation mediating PPARD axis","volume":"11","author":"Xu","year":"2025","journal-title":"Cell Death. Discov."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0077","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4143\/crt.2023.800","article-title":"Next-generation sequencing in breast cancer patients: real-world data for precision medicine","volume":"56","author":"Lee","year":"2024","journal-title":"Cancer Res. Treat."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101454_bib0078","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.3390\/cancers14092161","article-title":"PI3K inhibitors in advanced breast cancer: the past, the present, new challenges and future perspectives","volume":"14","author":"Fuso","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ctarc.2026.101454_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2025.105881","article-title":"Emerging molecular therapeutic targets in breast cancer: pathologic identification and clinical implications","volume":"162","author":"Sahin","year":"2025","journal-title":"Hum. Pathol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/17501911.2025.2460900","article-title":"A narrative review of epigenetic marker in H3K27ac and its emerging potential as a therapeutic target in cancer","volume":"17","author":"Zhu","year":"2025","journal-title":"Epigenomics"},{"issue":"12","key":"10.1016\/j.ctarc.2026.101454_bib0081","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s12032-022-01815-8","article-title":"A critical review of datasets and computational suites for improving cancer theranostics and biomarker discovery","volume":"39","author":"Ashok","year":"2022","journal-title":"Med. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101454_bib0082","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3390\/cancers14030474","article-title":"Epigenetic therapies and biomarkers in breast cancer","volume":"14","author":"Brown","year":"2022","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101454_bib0083","doi-asserted-by":"crossref","DOI":"10.1002\/qub2.78","article-title":"Bioinformatics perspectives on transcriptomics: a comprehensive review of bulk and single-cell RNA sequencing analyses","volume":"13","author":"Tzec-Interi\u00e1n","year":"2025","journal-title":"Quant. Biol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101454_bib0084","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/0115748936352261241224053340","article-title":"An overview of spatial transcriptomics methodologies in traversing the biological system","volume":"21","author":"John","year":"2026","journal-title":"Curr. Bioinform."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101454_bib0085","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41576-025-00828-z","article-title":"Transcriptomics in the era of long-read sequencing","volume":"26","author":"Monz\u00f3","year":"2025","journal-title":"Nat. Rev. Genet."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101454_bib0086","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.3390\/ijms22031422","article-title":"Current achievements and applications of transcriptomics in personalized cancer medicine","volume":"22","author":"Supplitt","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0087","article-title":"Applications of transcriptomics methods in breast cancer","volume":"5","author":"G\u00f6kmen Polar","year":"2022","journal-title":"\u0130stanbul \u00dcniversitesi Sa\u011fl\u0131k Bilimleri Ara\u015ft\u0131rmalar\u0131 Dergisi"},{"issue":"16","key":"10.1016\/j.ctarc.2026.101454_bib0088","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.3390\/cancers15164164","article-title":"Advancing breast cancer heterogeneity analysis: insights from genomics, transcriptomics and proteomics at bulk and single-cell levels","volume":"15","author":"Zhu","year":"2023","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101454_bib0089","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/jcmm.17124","article-title":"Recent advances of transcriptomics and proteomics in triple-negative breast cancer prognosis assessment","volume":"26","author":"Li","year":"2022","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0090","doi-asserted-by":"crossref","first-page":"8170","DOI":"10.1038\/s41467-023-43991-9","article-title":"Single cell multi-omics reveal intra-cell-line heterogeneity across human cancer cell lines","volume":"14","author":"Zhu","year":"2023","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101454_bib0091","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3390\/cells10030648","article-title":"Prognostic cancer gene expression signatures: current status and challenges","volume":"10","author":"Qian","year":"2021","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101454_bib0092","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s40291-020-00482-7","article-title":"Oncotype DX breast recurrence Score\u00ae: a review of its use in early-stage breast cancer","volume":"24","author":"Syed","year":"2020","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.ctarc.2026.101454_bib0093","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2025.102887","article-title":"Current controversies in the use of oncotype DX in early breast cancer","volume":"135","author":"Berton Giachetti","year":"2025","journal-title":"Cancer Treat. Rev."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101454_bib0094","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1158\/1055-9965.EPI-13-1023","article-title":"Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics","volume":"23","author":"Sweeney","year":"2014","journal-title":"Cancer Epidemiol., Biomarkers Prev."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0095","article-title":"Analysis of tumor microenvironment heterogeneity among breast cancer subtypes to identify subtype-specific signatures","volume":"14","author":"Li","year":"2023","journal-title":"Genes [Internet]"},{"issue":"14","key":"10.1016\/j.ctarc.2026.101454_bib0096","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1016\/j.cell.2026.04.023","article-title":"AI-predicted spatial transcriptomics unlocks breast cancer biomarkers from pathology","volume":"189","author":"Shulman","year":"2026","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0097","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1007\/s12672-025-03068-z","article-title":"Single\u2011cell RNA sequencing reveals TMEM71 as an immunomodulatory biomarker predicting immune checkpoint blockade response in breast cancer","volume":"16","author":"Li","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.ctarc.2026.101454_bib0098","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2025.100287","article-title":"Potential applications of gene expression profiles obtained from circulating extracellular vesicles in breast cancer","volume":"7","author":"Gupta","year":"2025","journal-title":"J. Liquid Biopsy"},{"issue":"12","key":"10.1016\/j.ctarc.2026.101454_bib0099","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.3390\/cancers15123237","article-title":"Identification of novel diagnostic and prognostic gene signature biomarkers for breast cancer using artificial intelligence and machine learning assisted transcriptomics analysis","volume":"15","author":"Mirza","year":"2023","journal-title":"Cancers"},{"issue":"02","key":"10.1016\/j.ctarc.2026.101454_bib0100","doi-asserted-by":"crossref","first-page":"01","DOI":"10.55218\/JASR.2025160201","article-title":"Proteomics and their applications to biology- A short review","volume":"16","author":"Ghosh","year":"2025","journal-title":"JASR"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101454_bib0101","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/jpm15050177","article-title":"Proteomics in diagnostic evaluation and treatment of breast cancer: a scoping review","volume":"15","author":"Zafrakas","year":"2025","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.ctarc.2026.101454_bib0102","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2024.117122","article-title":"Proteomics-on-a-chip - microfluidics meets proteomics","volume":"273","author":"Zhang","year":"2025","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.ctarc.2026.101454_bib0103","doi-asserted-by":"crossref","first-page":"275","DOI":"10.31557\/apjcb.2022.7.3.275-283","article-title":"Accelerating breast cancer biomarker discovery by mass spectrometry proteomics and current bioinformatics tools","volume":"7","author":"Cation","year":"2022","journal-title":"Asian Pacific J. Cancer Biol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0104","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/proteomes10040035","article-title":"Proteomics-based identification of dysregulated proteins in breast cancer","volume":"10","author":"Neagu","year":"2022","journal-title":"Proteomes"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12014-025-09526-8","article-title":"Integrating functional proteomics and next generation sequencing reveals potential therapeutic targets for Taiwanese breast cancer","volume":"22","author":"Ku","year":"2025","journal-title":"Clin. Proteomics."},{"key":"10.1016\/j.ctarc.2026.101454_bib0106","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4314\/sokjmls.v10i1.28","article-title":"Cancer biomarkers: molecular insights and implications for targeted therapy","volume":"10","author":"Anura","year":"2025","journal-title":"Sokoto J. Med. Lab. Sci."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101454_bib0107","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1021\/acs.jproteome.5b01091","article-title":"A description of the clinical proteomic tumor Analysis Consortium (CPTAC) common data Analysis pipeline","volume":"15","author":"Rudnick","year":"2016","journal-title":"J. Proteome Res."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101454_bib0108","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/proteomes11020013","article-title":"Proteomics-based identification of dysregulated proteins and biomarker discovery in invasive ductal carcinoma, the most common breast cancer subtype","volume":"11","author":"Neagu","year":"2023","journal-title":"Proteomes"},{"key":"10.1016\/j.ctarc.2026.101454_bib0109","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2023.104955","article-title":"High-throughput proteomics of breast cancer subtypes: biological characterization and multiple candidate biomarker panels to patients' stratification","volume":"285","author":"Azevedo","year":"2023","journal-title":"J. Proteomics."},{"key":"10.1016\/j.ctarc.2026.101454_bib0110","doi-asserted-by":"crossref","first-page":"900","DOI":"10.30574\/ijsra.2025.14.3.0753","article-title":"LC-MS in proteomics and biomarker discovery","volume":"14","author":"Farmaan","year":"2025","journal-title":"Int. J. Sci. Res. Archive"},{"key":"10.1016\/j.ctarc.2026.101454_bib0111","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.155938","article-title":"Proteomic insights into lymph node metastasis in breast cancer subtypes: key biomarkers and pathways","volume":"269","author":"Bal Albayrak","year":"2025","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0112","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/qub2.35","article-title":"Proteomics techniques in protein biomarker discovery","volume":"12","author":"Babaei","year":"2024","journal-title":"Quant. Biol."},{"key":"10.1016\/j.ctarc.2026.101454_bib0113","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.4314\/ijbcs.v17i7.26","article-title":"Proteomics analysis techniques and bioinformatics approaches for biomarkers discovery","volume":"17","author":"Diouf","year":"2024","journal-title":"Int. J. Biol. Chem. Sci."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0114","first-page":"1","article-title":"A review of prognostic and predictive biomarkers in breast cancer","volume":"23","author":"Tarighati","year":"2023","journal-title":"Clin. Exp. Med."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0115","article-title":"Targeted therapies for each subtype of breast cancer","volume":"7","author":"Liu","year":"2026","journal-title":"MedComm. (2020)"},{"issue":"11","key":"10.1016\/j.ctarc.2026.101454_bib0116","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.mpdhp.2014.10.002","article-title":"ER, PR and HER2 testing in breast cancer","volume":"20","author":"Han","year":"2014","journal-title":"Diagn. Histopathol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101454_bib0117","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s13205-025-04222-8","article-title":"Relevance of proteomics and metabolomics approaches to overview the tumorigenesis and better management of cancer","volume":"15","author":"Singh","year":"2025","journal-title":"3. Biotech."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101454_bib0118","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btaf182","article-title":"Functional protein biomarkers based on distributions of expression levels in single-cell imaging data","volume":"41","author":"Yi","year":"2025","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ctarc.2026.101454_bib0119","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104950","article-title":"Proteomics signatures of human breast cancer: a systematic review","volume":"216","author":"Garc\u00eda-Chico","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0120","doi-asserted-by":"crossref","first-page":"8991","DOI":"10.1038\/s41598-023-36159-4","article-title":"Quantifiable peptide library bridges the gap for proteomics based biomarker discovery and validation on breast cancer","volume":"13","author":"Kim","year":"2023","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101454_bib0121","doi-asserted-by":"crossref","DOI":"10.3390\/proteomes11020017","article-title":"Spatial proteomics for the molecular characterization of breast cancer","volume":"11","author":"Bro\u017eov\u00e1","year":"2023","journal-title":"Proteomes"},{"key":"10.1016\/j.ctarc.2026.101454_bib0122","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1449668","article-title":"Identifying new biomarkers and potential therapeutic targets for breast cancer through the integration of human plasma proteomics: a Mendelian randomization study and colocalization analysis","volume":"15","author":"Song","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ctarc.2026.101454_bib0123","doi-asserted-by":"crossref","DOI":"10.3389\/fragi.2023.1191993","article-title":"Variant biomarker discovery using mass spectrometry-based proteogenomics","volume":"4","author":"Reilly","year":"2023","journal-title":"Front. Aging"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0124","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/proteomes10040036","article-title":"Mass spectrometry-based proteomics of Human milk to identify differentially expressed proteins in women with breast cancer versus controls","volume":"10","author":"Aslebagh","year":"2022","journal-title":"Proteomes"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0125","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.3390\/ijms24044164","article-title":"Potential early markers for breast cancer: a proteomic approach comparing saliva and serum samples in a pilot study","volume":"24","author":"Sinha","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2026.101454_bib0126","doi-asserted-by":"crossref","DOI":"10.1155\/bri\/5584607","article-title":"Exploring molecular alterations in breast cancer among Indian women using label-free quantitative serum proteomics","volume":"2024","author":"Tomar","year":"2024","journal-title":"Biochem. Res. Int."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101454_bib0127","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1021\/acs.jproteome.4c00295","article-title":"Evaluation of a proteomics-guided protein signature for breast cancer detection in breast tissue","volume":"23","author":"Moreno-Ulloa","year":"2024","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0128","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12943-023-01741-x","article-title":"Recent advances of small extracellular vesicle biomarkers in breast cancer diagnosis and prognosis","volume":"22","author":"Lee","year":"2023","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101454_bib0129","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16030520","article-title":"Surface proteome of extracellular vesicles and correlation analysis reveal breast cancer biomarkers","volume":"16","author":"H\u00fcttmann","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.ctarc.2026.101454_bib0130","article-title":"Extracellular vesicle biomarkers: current status and future perspectives as novel tools in liquid biopsy","volume":"17","author":"Huang","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101454_bib0131","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinbiochem.2024.110776","article-title":"Exploring novel protein-based biomarkers for advancing breast cancer diagnosis: a review","volume":"129","author":"Vellan","year":"2024","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ctarc.2026.101454_bib0132","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2024.1436393","article-title":"Tumor-on-chip platforms for breast cancer continuum concept modeling","volume":"12","author":"Neagu","year":"2024","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101454_bib0133","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.3390\/cancers15102780","article-title":"Biomarker reproducibility Challenge: a review of non-nucleotide Biomarker discovery protocols from body fluids in breast cancer diagnosis","volume":"15","author":"Safari","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0134","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-023-01399-3","article-title":"Small molecule metabolites: discovery of biomarkers and therapeutic targets","volume":"8","author":"Qiu","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0135","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40364-023-00507-3","article-title":"Cancer metabolites: promising biomarkers for cancer liquid biopsy","volume":"11","author":"Wang","year":"2023","journal-title":"Biomark. Res."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101454_bib0136","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3390\/metabo15070428","article-title":"Metabolomics in breast cancer: from biomarker discovery to personalized medicine","volume":"15","author":"Perestrelo","year":"2025","journal-title":"Metabolites"},{"key":"10.1016\/j.ctarc.2026.101454_bib0137","doi-asserted-by":"crossref","first-page":"6797","DOI":"10.2147\/OTT.S215628","article-title":"Metabolomics: a promising diagnostic and therapeutic implement for breast cancer","volume":"Volume 12","author":"Chen","year":"2019","journal-title":"Onco Targets. Ther."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0138","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/cells14010005","article-title":"Metabolomics-driven biomarker discovery for breast cancer prognosis and diagnosis","volume":"14","author":"Kaur","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.ctarc.2026.101454_bib0139","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cca.2013.05.003","article-title":"Metabolomics in noninvasive breast cancer","volume":"424","author":"Zhang","year":"2013","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0140","article-title":"Proposed comprehensive methodology integrated with explainable artificial intelligence for prediction of possible biomarkers in metabolomics panel of plasma samples for breast cancer detection","volume":"61","author":"Colak","year":"2025","journal-title":"Medicina (Kaunas)"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101454_bib0141","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0311810","article-title":"Combining metabolomics and machine learning to discover biomarkers for early-stage breast cancer diagnosis","volume":"19","author":"Anh","year":"2024","journal-title":"PLoS. One"},{"issue":"21","key":"10.1016\/j.ctarc.2026.101454_bib0142","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252111835","article-title":"Identification of a novel biomarker panel for breast cancer screening","volume":"25","author":"Vaida","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2026.101454_bib0143","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1426964","article-title":"Biomarker discovery and development of prognostic prediction model using metabolomic panel in breast cancer patients: a hybrid methodology integrating machine learning and explainable artificial intelligence","volume":"11","author":"Yagin","year":"2024","journal-title":"Front. Mol. Biosci."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0144","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3892\/mco.2025.2830","article-title":"Exploring the complex relationship between metabolomics and breast cancer early detection (Review)","volume":"22","author":"Alshajrawi","year":"2025","journal-title":"Mol. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0145","doi-asserted-by":"crossref","first-page":"353","DOI":"10.22452\/jummec.sp2023no1.37","article-title":"Decoding the endogenous metabolome of breast cancer: analytical approaches and chemometric intervention. A systematic review","volume":"sp2023","author":"Mohd Zain","year":"2023","journal-title":"JUMMEC"},{"key":"10.1016\/j.ctarc.2026.101454_bib0146","doi-asserted-by":"crossref","DOI":"10.36877\/pmmb.a0000392","article-title":"Identification of potential biomarkers and metabolic changes in the serum of breast lump patients among Kelantanese based on 1H NMR metabolomics","volume":"6","author":"Zulkefly","year":"2023","journal-title":"Progress Microbes Molec. Biol."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101454_bib0147","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.3390\/biomedicines11071845","article-title":"Nutritional metabolomics in diet-breast cancer relations: current research, challenges, and future directions-A review","volume":"11","author":"Vahid","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0148","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tem.2025.04.008","article-title":"Metabolomics-enabled biomarker discovery in breast cancer research","volume":"37","author":"F\u00fcreder","year":"2026","journal-title":"Trends. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101454_bib0149","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11306-023-02024-8","article-title":"Metabolomics unravels subtype-specific characteristics related to neoadjuvant therapy response in breast cancer patients","volume":"19","author":"Zapater-Moros","year":"2023","journal-title":"Metabolomics"},{"key":"10.1016\/j.ctarc.2026.101454_bib0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.119836","article-title":"A critical appraisal of the role of metabolomics in breast cancer research and diagnostics","volume":"561","author":"Gadwal","year":"2024","journal-title":"Clin. Chim. Acta"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101454_bib0151","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3390\/metabo15080514","article-title":"Machine learning-driven insights in cancer metabolomics: from subtyping to biomarker discovery and prognostic modeling","volume":"15","author":"Elguoshy","year":"2025","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0152","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00204-010-0609-6","article-title":"The role of metabolites and metabolomics in clinically applicable biomarkers of disease","volume":"85","author":"Mamas","year":"2011","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101454_bib0153","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/bfgp\/elac017","article-title":"Multiomics technologies: role in disease biomarker discoveries and therapeutics","volume":"22","author":"Dar","year":"2023","journal-title":"Brief. Funct. Genomics."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101454_bib0154","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/s41588-023-01466-z","article-title":"Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk","volume":"55","author":"Wilcox","year":"2023","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0155","article-title":"Somatic mutational landscape across Indian breast cancer cases by whole exome sequencing","volume":"14","author":"Kumar","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0156","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13148-024-01674-2","article-title":"Machine learning unveils an immune-related DNA methylation profile in germline DNA from breast cancer patients","volume":"16","author":"Lee","year":"2024","journal-title":"Clin. Epigenet."},{"issue":"19","key":"10.1016\/j.ctarc.2026.101454_bib0157","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.3390\/cancers16193379","article-title":"Secondary transcriptomic analysis of triple-negative breast cancer reveals reliable universal and subtype-specific mechanistic markers","volume":"16","author":"Rapier-Sharman","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0158","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/s12859-022-04965-8","article-title":"Breast cancer prediction with transcriptome profiling using feature selection and machine learning methods","volume":"23","author":"Taghizadeh","year":"2022","journal-title":"BMC. Bioinform."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101454_bib0159","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1021\/acs.jproteome.4c00295","article-title":"Evaluation of a proteomics-guided protein signature for breast cancer detection in breast tissue","volume":"23","author":"Moreno-Ulloa","year":"2024","journal-title":"J. Proteome Res."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101454_bib0160","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/1354750X.2025.2591717","article-title":"Emerging biomarkers in breast cancer: translational and multi-omics perspectives in precision oncology","volume":"30","author":"Yasmin","year":"2025","journal-title":"Biomarkers"},{"key":"10.1016\/j.ctarc.2026.101454_bib0161","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2026.105160","article-title":"Artificial intelligence and multi-omics convergence in breast cancer: revolutionizing diagnosis, prognostication, and precision oncology","volume":"220","author":"Jiang","year":"2026","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101454_bib0162","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0354728","article-title":"Diagnostic accuracy of circulating microRNAs and lipidomic biomarkers for early breast cancer detection: a systematic review and meta-analysis","volume":"21","author":"Arafat","year":"2026","journal-title":"PLoS. One"},{"issue":"12","key":"10.1016\/j.ctarc.2026.101454_bib0163","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1007\/s12094-024-03541-1","article-title":"Biomarkers in breast cancer 2024: an updated consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology","volume":"26","author":"Colomer","year":"2024","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.ctarc.2026.101454_bib0164","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2011.0137","article-title":"NCCN Task Force report: evaluating the clinical utility of tumor markers in oncology","volume":"9","author":"Febbo","year":"2011","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101454_bib0165","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.molonc.2012.01.010","article-title":"Cancer biomarkers","volume":"6","author":"Henry","year":"2012","journal-title":"Mol. Oncol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0166","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrclinonc.2013.30","article-title":"Validation and clinical utility of prostate cancer biomarkers","volume":"10","author":"Scher","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101454_bib0167","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.breast.2023.04.003","article-title":"External validation of 87 clinical prediction models supporting clinical decisions for breast cancer patients","volume":"69","author":"Hueting","year":"2023","journal-title":"Breast"},{"key":"10.1016\/j.ctarc.2026.101454_bib0168","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpi.2024.100363","article-title":"Publicly available datasets of breast histopathology H&E whole-slide images: a scoping review","volume":"15","author":"Tafavvoghi","year":"2024","journal-title":"J. Pathol. Inform."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0169","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae628","article-title":"Comprehensive bioinformatics and machine learning analyses for breast cancer staging using TCGA dataset","volume":"26","author":"Das","year":"2024","journal-title":"Brief. Bioinform."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0170","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.3390\/ijms26041707","article-title":"Heterogeneous clustering of multiomics data for breast cancer subgroup classification and detection","volume":"26","author":"Pateras","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0171","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s43046-025-00260-8","article-title":"Identification of key biomarkers in breast cancer based on bioinformatics analysis and experimental verification","volume":"37","author":"Huan","year":"2025","journal-title":"J. Egypt. Natl. Canc. Inst."},{"key":"10.1016\/j.ctarc.2026.101454_bib0172","doi-asserted-by":"crossref","DOI":"10.3389\/fbinf.2025.1644695","article-title":"BC-predict: mining of signal biomarkers and production of models for early-stage breast cancer subtyping and prognosis","volume":"5","author":"Muthamilselvan","year":"2025","journal-title":"Front. Bioinform."},{"key":"10.1016\/j.ctarc.2026.101454_bib0173","article-title":"Multimodal data-driven intelligent systems for breast cancer prediction","volume":"10","author":"Kanimozhi","year":"2024","journal-title":"EAI. Endorsed. Trans. Pervas, Health Technol."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101454_bib0174","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3390\/genes15081036","article-title":"A comprehensive review of bioinformatics tools for Genomic biomarker discovery driving precision oncology","volume":"15","author":"Clark","year":"2024","journal-title":"Genes. (Basel)"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101454_bib0175","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00432-025-06271-1","article-title":"The assessment of breast cancer biomarkers in diagnosis, prognosis and treatment monitoring: integrated analysis","volume":"151","author":"Kr\u00f3lewska-Daszczy\u0144ska","year":"2025","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.ctarc.2026.101454_bib0176","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316771","article-title":"Targeting the tumor microenvironment in breast cancer: prognostic and predictive significance and therapeutic opportunities","volume":"24","author":"Dom\u00ednguez-Cejudo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.ctarc.2026.101454_bib0177","doi-asserted-by":"crossref","first-page":"12674","DOI":"10.18632\/aging.205205","article-title":"Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels the heterogeneity of cancer-associated fibroblasts in TNBC","volume":"15","author":"Wu","year":"2023","journal-title":"Aging (Albany. NY)"},{"key":"10.1016\/j.ctarc.2026.101454_bib0178","article-title":"CD2 Is a novel immune-related prognostic biomarker of invasive breast carcinoma that modulates the tumor microenvironment","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0179","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s12672-025-03549-1","article-title":"Novel radiation-derived gene blueprint stratifying patients with breast cancer","volume":"16","author":"Zhang","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.ctarc.2026.101454_bib0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102223","article-title":"Precision medicine in breast cancer: from clinical trials to clinical practice","volume":"98","author":"Crimini","year":"2021","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0181","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00268-9","article-title":"Screening and predicted value of potential biomarkers for breast cancer using bioinformatics analysis","volume":"11","author":"Zeng","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ctarc.2026.101454_bib0182","first-page":"1","article-title":"Determination of genetic and epigenetic modifications-related prognostic biomarkers of breast cancer: genome high-throughput data analysis","volume":"2021","author":"Gao","year":"2021","journal-title":"J. Oncol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101454_bib0183","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","article-title":"Emerging concepts of miRNA therapeutics: from cells to clinic","volume":"38","author":"Diener","year":"2022","journal-title":"Trends. Genet."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101454_bib0184","doi-asserted-by":"crossref","first-page":"9360","DOI":"10.3390\/ijms24119360","article-title":"The mechanism of DNA methylation and miRNA in breast cancer","volume":"24","author":"Ma","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2026.101454_bib0185","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.canlet.2021.04.002","article-title":"LncRNA-miRNA axes in breast cancer: novel points of interaction for strategic attack","volume":"509","author":"Venkatesh","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ctarc.2026.101454_bib0186","first-page":"1","article-title":"The emerging role of MicroRNAs in breast cancer","volume":"2020","author":"Yang","year":"2020","journal-title":"J. Oncol."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101454_bib0187","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.440","article-title":"Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers","volume":"8","author":"Hamam","year":"2017","journal-title":"Cell Death. Dis."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101454_bib0188","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s10555-020-09905-7","article-title":"Regulation of breast cancer metastasis signaling by miRNAs","volume":"39","author":"Petri","year":"2020","journal-title":"Cancer Metastasis Rev."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0189","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12943-022-01506-y","article-title":"The double agents in liquid biopsy: promoter and informant biomarkers of early metastases in breast cancer","volume":"21","author":"Richard","year":"2022","journal-title":"Mol. Cancer"},{"issue":"19","key":"10.1016\/j.ctarc.2026.101454_bib0190","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.3390\/ijms20194940","article-title":"The regulatory role of MicroRNAs in breast cancer","volume":"20","author":"Loh","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101454_bib0191","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.3390\/cancers14092052","article-title":"Current and developing liquid biopsy techniques for breast cancer","volume":"14","author":"Wu","year":"2022","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0192","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.047662","article-title":"miRNA interplay: mechanisms and consequences in cancer","volume":"14","author":"Hill","year":"2021","journal-title":"Dis. Model. Mech."},{"issue":"16","key":"10.1016\/j.ctarc.2026.101454_bib0193","doi-asserted-by":"crossref","first-page":"9371","DOI":"10.3390\/ijms23169371","article-title":"Breast cancer-delivered exosomal miRNA as liquid biopsy biomarkers for metastasis prediction: a focus on translational research with clinical applicability","volume":"23","author":"Baldasici","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2026.101454_bib0194","article-title":"Potential utility of miRNAs for liquid biopsy in breast cancer","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101454_bib0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188413","article-title":"The emerging role of miRNA clusters in breast cancer progression","volume":"1874","author":"Kandettu","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101454_bib0196","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1053\/j.gastro.2022.06.089","article-title":"A liquid biopsy signature for the detection of patients with early-onset colorectal cancer","volume":"163","author":"Nakamura","year":"2022","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101454_bib0197","doi-asserted-by":"crossref","first-page":"678","DOI":"10.5858\/arpa.2019-0559-RA","article-title":"Liquid biopsy in breast cancer: a focused review","volume":"145","author":"Tay","year":"2021","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"16","key":"10.1016\/j.ctarc.2026.101454_bib0198","doi-asserted-by":"crossref","first-page":"8845","DOI":"10.3390\/ijms23168845","article-title":"Exosomes in breast cancer: involvement in tumor dissemination and prospects for liquid biopsy","volume":"23","author":"Shefer","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0199","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12282-024-01563-9","article-title":"Prospects for liquid biopsy using microRNA and extracellular vesicles in breast cancer","volume":"32","author":"Ochiya","year":"2025","journal-title":"Breast. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0200","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/jpm11010031","article-title":"miR-210 and miR-152 as biomarkers by liquid biopsy in invasive ductal carcinoma","volume":"11","author":"Lopes","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.ctarc.2026.101454_bib0201","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-3-031-08356-3_2","article-title":"Circulating MicroRNAs as cancer biomarkers in liquid biopsies","volume":"1385","author":"Su\u00e1rez","year":"2022","journal-title":"Adv. Exp. Med. Biol."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101454_bib0202","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/cancers14092317","article-title":"Circulating miRNAs in breast cancer diagnosis and prognosis","volume":"14","author":"Cardinali","year":"2022","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0203","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.3390\/ijms24043910","article-title":"An epidemiological systematic review with meta-analysis on biomarker role of circulating MicroRNAs in breast cancer incidence","volume":"24","author":"Padroni","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0204","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3390\/cells12040525","article-title":"Potential miRNA use as a biomarker: from breast cancer diagnosis to metastasis","volume":"12","author":"Jordan-Alejandre","year":"2023","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101454_bib0205","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/CAD.0000000000000498","article-title":"MicroRNA-148a promotes apoptosis and suppresses growth of breast cancer cells by targeting B-cell lymphoma 2","volume":"28","author":"Li","year":"2017","journal-title":"Anticancer Drugs"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101454_bib0206","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/kjm2.12085","article-title":"MicroRNA-26a-5p inhibits breast cancer cell growth by suppressing RNF6 expression","volume":"35","author":"Huang","year":"2019","journal-title":"Kaohsiung. J. Med. Sci."},{"key":"10.1016\/j.ctarc.2026.101454_bib0207","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1186\/s12885-016-2620-7","article-title":"Overexpression of the miR-141\/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K\/AKT signaling pathways by secreting VEGF-A","volume":"16","author":"Choi","year":"2016","journal-title":"BMC. Cancer"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0208","first-page":"1162","article-title":"MicroRNA-200a suppresses the wnt\/\u03b2-catenin signaling pathway by interacting with \u03b2-catenin","volume":"40","author":"Su","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ctarc.2026.101454_bib0209","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2407-14-134","article-title":"Epigenetic silencing of miR-375 induces trastuzumab resistance in HER2-positive breast cancer by targeting IGF1R","volume":"14","author":"Ye","year":"2014","journal-title":"BMC. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.yexcr.2017.10.005","article-title":"Establishment of twist-1 and TGFBR2 as direct targets of microRNA-20a in mesenchymal to epithelial transition of breast cancer cell-line MDA-MB-231","volume":"361","author":"De","year":"2017","journal-title":"Exp. Cell Res."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101454_bib0211","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.3892\/ijmm.2016.2518","article-title":"MicroRNA-214 acts as a potential oncogene in breast cancer by targeting the PTEN-PI3K\/Akt signaling pathway","volume":"37","author":"Wang","year":"2016","journal-title":"Int. J. Mol. Med."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101454_bib0212","doi-asserted-by":"crossref","first-page":"8993","DOI":"10.1007\/s13277-015-4513-9","article-title":"MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway","volume":"37","author":"Mohammadi-Yeganeh","year":"2016","journal-title":"Tumor Biol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101454_bib0213","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s12282-019-00989-w","article-title":"MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1","volume":"26","author":"Zhao","year":"2019","journal-title":"Breast. Cancer"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101454_bib0214","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/cas.12880","article-title":"Novel combination of serum microRNA for detecting breast cancer in the early stage","volume":"107","author":"Shimomura","year":"2016","journal-title":"Cancer Sci."},{"issue":"16","key":"10.1016\/j.ctarc.2026.101454_bib0215","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1002\/cam4.2572","article-title":"A five-miRNA panel in plasma was identified for breast cancer diagnosis","volume":"8","author":"Li","year":"2019","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0216","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3233\/CBM-201547","article-title":"MicroRNA profiling in serum: potential signatures for breast cancer diagnosis","volume":"30","author":"Zou","year":"2021","journal-title":"Cancer Biomark."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101454_bib0217","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41416-021-01593-6","article-title":"Development and validation of a circulating microRNA panel for the early detection of breast cancer","volume":"126","author":"Zou","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101454_bib0218","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1631\/jzus.B1900709","article-title":"Roles of miRNA and IncRNA in triple-negative breast cancer","volume":"21","author":"Xu","year":"2020","journal-title":"J. Zhejiang Univ.-Sci. B"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101454_bib0219","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.21873\/anticanres.12755","article-title":"Circulating pre-microRNA-488 in peripheral blood is a potential biomarker for predicting recurrence in breast cancer","volume":"38","author":"Masuda","year":"2018","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101454_bib0220","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1016\/j.ygeno.2020.02.015","article-title":"Identification and validation of immune-related lncRNA prognostic signature for breast cancer","volume":"112","author":"Shen","year":"2020","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0221","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12935-021-01916-w","article-title":"lncRNA APOC1P1-3 promoting anoikis-resistance of breast cancer cells","volume":"21","author":"Lu","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101454_bib0222","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/s41388-019-1040-y","article-title":"Long noncoding RNAs and exosomal lncRNAs: classification, and mechanisms in breast cancer metastasis and drug resistance","volume":"39","author":"Yousefi","year":"2020","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101454_bib0223","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2021.100709","article-title":"Clinical impact of LncRNA XIST and LncRNA NEAT1 for diagnosis of high-risk group breast cancer patients","volume":"45","author":"Swellam","year":"2021","journal-title":"Curr. Probl. Cancer"},{"key":"10.1016\/j.ctarc.2026.101454_bib0224","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.omtn.2021.08.005","article-title":"lncRNA and breast cancer: progress from identifying mechanisms to challenges and opportunities of clinical treatment","volume":"25","author":"Jin","year":"2021","journal-title":"Mol. Ther. Nucleic. Acids."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0225","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jcmm.15980","article-title":"A novel autophagy-related lncRNA prognostic risk model for breast cancer","volume":"25","author":"Li","year":"2021","journal-title":"J. Cell Mol. Med."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101454_bib0226","doi-asserted-by":"crossref","first-page":"8095","DOI":"10.3390\/ijms24098095","article-title":"Interplay between LncRNAs and microRNAs in breast cancer","volume":"24","author":"Schwarzenbach","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101454_bib0227","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.3390\/cancers14092101","article-title":"The mechanisms of lncRNA-mediated multidrug resistance and the clinical application prospects of lncRNAs in breast cancer","volume":"14","author":"Ye","year":"2022","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101454_bib0228","first-page":"497","article-title":"lncRNA CYTOR promotes tamoxifen resistance in breast cancer cells via sponging miR\u2011125a\u20115p","volume":"45","author":"Liu","year":"2020","journal-title":"Int. J. Mol. Med."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101454_bib0229","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ncrna.2021.08.001","article-title":"Long non-coding RNAs in oncourology","volume":"6","author":"Gareev","year":"2021","journal-title":"Noncoding. RNa Res."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101454_bib0230","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41419-020-2557-2","article-title":"LncRNA SNORD3A specifically sensitizes breast cancer cells to 5-FU by sponging miR-185-5p to enhance UMPS expression","volume":"11","author":"Luo","year":"2020","journal-title":"Cell Death. Dis."},{"issue":"17","key":"10.1016\/j.ctarc.2026.101454_bib0231","doi-asserted-by":"crossref","first-page":"7351","DOI":"10.7150\/thno.74753","article-title":"Cancer-associated fibroblasts facilitate premetastatic niche formation through lncRNA SNHG5-mediated angiogenesis and vascular permeability in breast cancer","volume":"12","author":"Zeng","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.ctarc.2026.101454_bib0232","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12935-020-01261-4","article-title":"LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53\/TNFAIP8 pathway","volume":"20","author":"Li","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ctarc.2026.101454_bib0233","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118193","article-title":"Serum LncRNA-ATB and FAM83H-AS1 as diagnostic\/prognostic non-invasive biomarkers for breast cancer","volume":"259","author":"El-Ashmawy","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.ctarc.2026.101454_bib0234","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/9997212","article-title":"Serum-based lncRNA ANRIL, TUG1, UCA1, and HIT expressions in breast cancer patients","volume":"2022","author":"Alkhathami","year":"2022","journal-title":"Dis. Markers"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101454_bib0235","doi-asserted-by":"crossref","first-page":"7685","DOI":"10.1007\/s11033-020-05841-5","article-title":"The clinical significance of circulating DSCAM-AS1 in patients with ER-positive breast cancer and construction of its competitive endogenous RNA network","volume":"47","author":"Moradi","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ctarc.2026.101454_bib0236","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153268","article-title":"LncRNA SPINT1-AS1 promotes breast cancer proliferation and metastasis by sponging let-7 a\/b\/i-5p","volume":"217","author":"Zhou","year":"2021","journal-title":"Pathol. Res. Pract."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0237","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24302","article-title":"Necroptosis-related lncRNA to establish novel prognostic signature and predict the immunotherapy response in breast cancer","volume":"36","author":"Chen","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101454_bib0238","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1016\/j.asjsur.2023.05.174","article-title":"Identification of prognostic melatonin-related lncRNA signature in tumor immune microenvironment and drug resistance for breast cancer","volume":"46","author":"Gao","year":"2023","journal-title":"Asian J. Surg."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0239","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s10142-023-00963-y","article-title":"Prognostic and immune microenvironment analysis of cuproptosis-related LncRNAs in breast cancer","volume":"23","author":"Pan","year":"2023","journal-title":"Funct. Integr. Genomics."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0240","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3233\/CBM-210545","article-title":"Construction of a lncRNA-mediated ceRNA network and a genomic-clinicopathologic nomogram to predict survival for breast cancer patients","volume":"36","author":"Wu","year":"2023","journal-title":"Cancer Biomark."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101454_bib0241","doi-asserted-by":"crossref","first-page":"11971","DOI":"10.1002\/cam4.5872","article-title":"Inhibition of lncRNA PCAT19 promotes breast cancer proliferation","volume":"12","author":"Feng","year":"2023","journal-title":"Cancer Med."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101454_bib0242","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.31333","article-title":"LncRNA AFAP1-AS1 mediates breast cancer cell proliferation and migration through the miR-21\/PTEN axis","volume":"239","author":"Quan","year":"2024","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.ctarc.2026.101454_bib0243","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.112074","article-title":"LncRNA LINC00667 inhibits breast cancer progression by regulating POTEE to suppress mitochondrial oxidative phosphorylation","volume":"135","author":"Yu","year":"2025","journal-title":"Cell Signal."},{"key":"10.1016\/j.ctarc.2026.101454_bib0244","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-079603","article-title":"Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial","volume":"387","author":"He","year":"2024","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0245","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1186\/s12885-019-6077-3","article-title":"Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer","volume":"19","author":"Bayarmaa","year":"2019","journal-title":"BMC. Cancer"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101454_bib0246","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/abbs\/gmab098","article-title":"lncRNA NEAT1 promotes the Taxol resistance of breast cancer via sponging the miR-23a-3p-FOXA1 axis","volume":"53","author":"Zhu","year":"2021","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0247","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15384047.2022.2132008","article-title":"LncRNA DUXAP8 induces breast cancer radioresistance by modulating the PI3K\/AKT\/mTOR pathway and the EZH2-E-cadherin\/RHOB pathway","volume":"23","author":"Lei","year":"2022","journal-title":"Cancer Biol. Ther."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0248","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.2149","article-title":"Association of long noncoding RNA biomarkers with clinical immune subtype and prediction of immunotherapy response in patients with cancer","volume":"3","author":"Yu","year":"2020","journal-title":"JAMa Netw. Open."},{"issue":"42","key":"10.1016\/j.ctarc.2026.101454_bib0249","article-title":"LncRNA FAISL inhibits calpain 2-mediated proteolysis of FAK to promote progression and metastasis of triple negative breast cancer","volume":"11","author":"Zhang","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101454_bib0250","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41419-024-07020-x","article-title":"LncRNA HAGLROS promotes breast cancer evolution through miR-135b-3p\/COL10A1 axis and exosome-mediated macrophage M2 polarization","volume":"15","author":"Meng","year":"2024","journal-title":"Cell Death. Dis."},{"issue":"13","key":"10.1016\/j.ctarc.2026.101454_bib0251","doi-asserted-by":"crossref","first-page":"6810","DOI":"10.3390\/ijms22136810","article-title":"Long noncoding RNA GAS5 in breast cancer: epigenetic mechanisms and biological functions","volume":"22","author":"Filippova","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0252","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12943-025-02510-8","article-title":"BRRIAR lncRNA alters breast cancer risk by modulating interferon signaling in cis and in trans","volume":"25","author":"Sivakumaran","year":"2026","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101454_bib0253","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190489","article-title":"LncRNA LUCAT1 facilitates tumorigenesis and metastasis of triple-negative breast cancer through modulating miR-5702","volume":"39","author":"Mou","year":"2019","journal-title":"Biosci. Rep."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101454_bib0254","doi-asserted-by":"crossref","first-page":"9105","DOI":"10.1002\/jcp.27587","article-title":"LncRNA-CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215","volume":"234","author":"Kong","year":"2019","journal-title":"J. Cell Physiol."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101454_bib0255","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1631\/jzus.B2300067","article-title":"Roles of lncRNA in the diagnosis and prognosis of triple-negative breast cancer","volume":"24","author":"Yang","year":"2023","journal-title":"J. Zhejiang. Univ. Sci. B"},{"issue":"15","key":"10.1016\/j.ctarc.2026.101454_bib0256","doi-asserted-by":"crossref","first-page":"8456","DOI":"10.3390\/ijms25158456","article-title":"Comprehensive transcriptome analysis expands lncRNA functional profiles in breast cancer","volume":"25","author":"Zhu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101454_bib0257","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1002\/jcp.29442","article-title":"Critical roles of long noncoding RNAs in breast cancer","volume":"235","author":"Abolghasemi","year":"2020","journal-title":"J. Cell Physiol."},{"issue":"16","key":"10.1016\/j.ctarc.2026.101454_bib0258","doi-asserted-by":"crossref","first-page":"8427","DOI":"10.3390\/ijms22168427","article-title":"The role of lncRNA in the development of tumors, including breast cancer","volume":"22","author":"Smolarz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101454_bib0259","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.3390\/ijms24087426","article-title":"The clinical utility of lncRNAs and their application as molecular biomarkers in breast cancer","volume":"24","author":"Arriaga-Canon","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2026.101454_bib0260","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.692170","article-title":"Unraveling immune-related lncRNAs in breast cancer molecular subtypes","volume":"11","author":"Mathias","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101454_bib0261","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12966","article-title":"The long non-coding RNA landscape in triple-negative breast cancer","volume":"54","author":"Zhang","year":"2021","journal-title":"Cell Prolifer."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0262","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07357907.2019.1695816","article-title":"A novel lncRNA HOXC-AS3 acts as a miR-3922-5p sponge to promote breast cancer metastasis","volume":"38","author":"Shi","year":"2020","journal-title":"Cancer Invest."},{"issue":"6478","key":"10.1016\/j.ctarc.2026.101454_bib0263","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.ctarc.2026.101454_bib0264","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.7150\/thno.113650","article-title":"Exosomes: innovative biomarkers leading the charge in non-invasive cancer diagnostics","volume":"15","author":"Li","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.ctarc.2026.101454_bib0265","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1615433","article-title":"Exosomal ncRNAs in liquid biopsy: a new paradigm for early cancer diagnosis and monitoring","volume":"15","author":"Ghani","year":"2025","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101454_bib0266","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.3390\/cancers12071827","article-title":"Exosomal MicroRNAs and organotropism in breast cancer metastasis","volume":"12","author":"Wong","year":"2020","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101454_bib0267","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/ijc.31774","article-title":"Exosomes play roles in sequential processes of tumor metastasis","volume":"144","author":"Li","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ctarc.2026.101454_bib0268","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.omtn.2019.04.027","article-title":"Emerging function and clinical values of exosomal MicroRNAs in cancer","volume":"16","author":"Wang","year":"2019","journal-title":"Mol. Ther. Nucleic. Acids."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101454_bib0269","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.1002\/jcp.29668","article-title":"Breast cancer-derived exosomes: tumor progression and therapeutic agents","volume":"235","author":"Jabbari","year":"2020","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.ctarc.2026.101454_bib0270","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v4.27066","article-title":"Biological properties of extracellular vesicles and their physiological functions","volume":"4","author":"Y\u00e1\u00f1ez-M\u00f3","year":"2015","journal-title":"J. ExtraCell Vesicles."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0271","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12943-022-01525-9","article-title":"Liquid biopsy: exosomal microRNAs as novel diagnostic and prognostic biomarkers in cancer","volume":"21","author":"Preethi","year":"2022","journal-title":"Mol. Cancer"},{"issue":"27","key":"10.1016\/j.ctarc.2026.101454_bib0272","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1002\/smll.201600725","article-title":"A single-cell assay for time lapse studies of exosome secretion and cell behaviors","volume":"12","author":"Chiu","year":"2016","journal-title":"Small"},{"key":"10.1016\/j.ctarc.2026.101454_bib0273","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.02.013","article-title":"Biogenesis and function of extracellular vesicles in cancer","volume":"188","author":"Bebelman","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"D1","key":"10.1016\/j.ctarc.2026.101454_bib0274","doi-asserted-by":"crossref","first-page":"D516","DOI":"10.1093\/nar\/gky1029","article-title":"Vesiclepedia 2019: a compendium of RNA, proteins, lipids and metabolites in extracellular vesicles","volume":"47","author":"Pathan","year":"2019","journal-title":"Nucleic. Acids. Res."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101454_bib0275","doi-asserted-by":"crossref","first-page":"386","DOI":"10.7555\/JBR.30.20150162","article-title":"Exosomes and their role in the micro-\/macro-environment: a comprehensive review","volume":"31","author":"Javeed","year":"2017","journal-title":"J. Biomed. Res."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101454_bib0276","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s00018-022-04552-3","article-title":"Tumor-derived exosomal non-coding RNAs as diagnostic biomarkers in cancer","volume":"79","author":"Ebrahimi","year":"2022","journal-title":"Cell Mol. Life Sci."},{"issue":"17","key":"10.1016\/j.ctarc.2026.101454_bib0277","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.3390\/cancers13174295","article-title":"Diagnostic and prognostic performance of liquid biopsy-derived exosomal MicroRNAs in thyroid cancer patients: a systematic review and meta-analysis","volume":"13","author":"Toraih","year":"2021","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101454_bib0278","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/CCO.0000000000001180","article-title":"Circulating tumor DNA in early-stage triple-negative breast cancer: clinical landscape and key open challenges","volume":"37","author":"De Placido","year":"2025","journal-title":"Curr. Opin. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0279","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s11033-024-10198-0","article-title":"Minimal residue disease detection in early-stage breast cancer: a review","volume":"52","author":"Zhang","year":"2025","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0280","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12885-025-13526-0","article-title":"Multiple time points for detecting circulating tumor DNA to monitor the response to neoadjuvant therapy in breast cancer: a meta-analysis","volume":"25","author":"Niu","year":"2025","journal-title":"BMC. Cancer"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101454_bib0281","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.102390","article-title":"Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysis","volume":"9","author":"Nader-Marta","year":"2024","journal-title":"ESMo Open."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101454_bib0282","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/1878-0261.13671","article-title":"Clinical applications of next-generation sequencing-based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression","volume":"19","author":"Klocker","year":"2025","journal-title":"Mol. Oncol."},{"issue":"3\u20134","key":"10.1016\/j.ctarc.2026.101454_bib0283","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/14622416.2026.2658438","article-title":"The use of cell-free DNA (cfDNA)\/circulating tumor DNA (ctDNA) to guide treatment selection in metastatic breast cancer","volume":"27","author":"Bello","year":"2026","journal-title":"Pharmacogenomics"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0284","doi-asserted-by":"crossref","DOI":"10.1177\/1559325819891004","article-title":"Isolation and detection technologies of extracellular vesicles and application on cancer diagnostic","volume":"17","author":"Ma","year":"2019","journal-title":"Dose Response"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101454_bib0285","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1039\/D0NA00676A","article-title":"Isolation and characterization of extracellular vesicles for clinical applications in cancer - time for standardization?","volume":"3","author":"Salmond","year":"2021","journal-title":"Nanoscale Adv."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101454_bib0286","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11112151","article-title":"Advances of exosomal miRNAs in breast cancer progression and diagnosis","volume":"11","author":"Chen","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.ctarc.2026.101454_bib0287","first-page":"59","article-title":"Critical analysis of the potential for microRNA biomarkers in breast cancer management","volume":"7","author":"Graveel","year":"2015","journal-title":"Breast. Cancer (Dove Med. Press)"},{"issue":"11","key":"10.1016\/j.ctarc.2026.101454_bib0288","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41556-019-0404-4","article-title":"Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis","volume":"21","author":"Rodrigues","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0289","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12929-019-0500-6","article-title":"Cross-talk between cancer cells and their neighbors via miRNA in extracellular vesicles: an emerging player in cancer metastasis","volume":"26","author":"Kogure","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ctarc.2026.101454_bib0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120342","article-title":"Exosome biomarkers in breast cancer: systematic review and meta-analysis","volume":"574","author":"Kang","year":"2025","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101454_bib0291","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10549-018-4757-3","article-title":"Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer","volume":"170","author":"Li","year":"2018","journal-title":"Breast. Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101454_bib0292","doi-asserted-by":"crossref","first-page":"749","DOI":"10.4103\/jcrt.jcrt_280_21","article-title":"Detection significance of miR-3662, miR-146a, and miR-1290 in serum exosomes of breast cancer patients","volume":"17","author":"Li","year":"2021","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.ctarc.2026.101454_bib0293","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5170261","article-title":"A breast cancer prediction model based on a panel from circulating exosomal miRNAs","volume":"2022","author":"Pan","year":"2022","journal-title":"BioMed. Res. Int."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101454_bib0294","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/1878-0261.13029","article-title":"Circulating exosomal miR-363-5p inhibits lymph node metastasis by downregulating PDGFB and serves as a potential noninvasive biomarker for breast cancer","volume":"15","author":"Wang","year":"2021","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0295","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12885-025-15499-6","article-title":"Identification of novel exosomal miRNAs and their role in diagnosis and prognosis of triple negative breast cancer","volume":"26","author":"Choudhary","year":"2026","journal-title":"BMC. Cancer"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0296","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3892\/ol.2024.14291","article-title":"Exploring miRNA\u2011target gene profiles associated with drug resistance in patients with breast cancer receiving neoadjuvant chemotherapy","volume":"27","author":"Kim","year":"2024","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101454_bib0297","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00280-020-04168-z","article-title":"Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer","volume":"86","author":"Zhang","year":"2020","journal-title":"Cancer Chemother Pharmacol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0298","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12967-024-04914-4","article-title":"Exosomal miR-361-3p promotes the viability of breast cancer cells by targeting ETV7 and BATF2 to upregulate the PAI-1\/ERK pathway","volume":"22","author":"Li","year":"2024","journal-title":"J. Transl. Med."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101454_bib0299","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/1354750X.2024.2406520","article-title":"Serum exosomal miR-200c is a potential diagnostic biomarker for breast cancer","volume":"29","author":"Qiao","year":"2024","journal-title":"Biomarkers"},{"key":"10.1016\/j.ctarc.2026.101454_bib0300","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2026.1716692","article-title":"Extracellular vesicle-associated and non-vesicle-associated microRNAs for early breast cancer detection: a systematic review","volume":"17","author":"Romero Urrego","year":"2026","journal-title":"Front. Genet."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0301","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s12282-024-01574-6","article-title":"Exosomal lncRNA SNHG12 promotes angiogenesis and breast cancer progression","volume":"31","author":"Chen","year":"2024","journal-title":"Breast. Cancer"},{"issue":"17","key":"10.1016\/j.ctarc.2026.101454_bib0302","doi-asserted-by":"crossref","first-page":"9952","DOI":"10.3390\/ijms23179952","article-title":"Liquid biopsy as a tool for the diagnosis, treatment, and monitoring of breast cancer","volume":"23","author":"Freitas","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.ctarc.2026.101454_bib0303","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.21037\/atm-21-3483","article-title":"Analysis of the expression profile of serum exosomal lncRNA in breast cancer patients","volume":"9","author":"Zhao","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ctarc.2026.101454_bib0304","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.2147\/OTT.S243601","article-title":"Determination of serum exosomal H19 as a noninvasive biomarker for breast cancer diagnosis","volume":"Volume 13","author":"Zhong","year":"2020","journal-title":"Onco Targets. Ther."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101454_bib0305","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24186","article-title":"High serum exosomal long non-coding RNA DANCR expression confers poor prognosis in patients with breast cancer","volume":"36","author":"Shi","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"issue":"16","key":"10.1016\/j.ctarc.2026.101454_bib0306","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.1111\/jcmm.16009","article-title":"Serum exosomal lncRNA XIST is a potential non-invasive biomarker to diagnose recurrence of triple-negative breast cancer","volume":"25","author":"Lan","year":"2021","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0307","first-page":"154","article-title":"Upregulation of serum exosomal SUMO1P3 predicts unfavorable prognosis in triple negative breast cancer","volume":"25","author":"Na-Er","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ctarc.2026.101454_bib0308","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.breast.2019.05.003","article-title":"Long non-coding RNA HOTAIR in circulatory exosomes is correlated with ErbB2\/HER2 positivity in breast cancer","volume":"46","author":"Wang","year":"2019","journal-title":"Breast"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101454_bib0309","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27104308","article-title":"Exosomal lncRNAs HOTAIR, HULC, and ANRIL: decoding the biomarker landscape of sporadic triple-negative breast cancer","volume":"27","author":"Sezginer Guler","year":"2026","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0310","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-023-01720-6","article-title":"Exosomal Linc00969 induces trastuzumab resistance in breast cancer by increasing HER-2 protein expression and mRNA stability by binding to HUR","volume":"25","author":"Liu","year":"2023","journal-title":"Breast. Cancer Res."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0311","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-025-03529-x","article-title":"Cancer-associated fibroblast promotes tamoxifen resistance in estrogen receptor positive breast cancer via exosomal LncRNA PRKCQ-AS1\/miR-200a-3p\/MKP1 axis-mediated apoptosis suppression","volume":"44","author":"Wu","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101454_bib0312","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117535","article-title":"A serum LncRNA signature for predicting prognosis of triple-negative breast cancer","volume":"549","author":"Zhu","year":"2023","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ctarc.2026.101454_bib0313","article-title":"Integration of imaging with liquid biopsy using artificial intelligence for ultra-early detection of breast cancer","volume":"5","author":"Ramgir-Naidu","year":"2026","journal-title":"Front. Imag."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101454_bib0314","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/14737140.2024.2362173","article-title":"Is ctDNA ready to outpace imaging in monitoring early and advanced breast cancer?","volume":"24","author":"Foffano","year":"2024","journal-title":"Expert. Rev. AntiCancer Ther."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-022-06728-8","article-title":"Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis","volume":"196","author":"Nguyen","year":"2022","journal-title":"Breast. Cancer Res. Treat."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101454_bib0316","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41551-018-0305-z","article-title":"Artificial intelligence in healthcare","volume":"2","author":"Yu","year":"2018","journal-title":"Nat. Biomed. Eng."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101454_bib0317","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1158\/1078-0432.CCR-18-3378","article-title":"Application of artificial intelligence for preoperative diagnostic and prognostic prediction in epithelial ovarian cancer based on blood biomarkers","volume":"25","author":"Kawakami","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101454_bib0318","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108276","article-title":"Integrated proteomic and glycoproteomic characterization of Human high-grade serous ovarian carcinoma","volume":"33","author":"Hu","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.ctarc.2026.101454_bib0319","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104001","article-title":"Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis","volume":"79","author":"Xiao","year":"2022","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0320","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.drudis.2020.10.002","article-title":"Deep learning in next-generation sequencing","volume":"26","author":"Schmidt","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ctarc.2026.101454_bib0321","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2026.105160","article-title":"Artificial intelligence and multi-omics convergence in breast cancer: revolutionizing diagnosis, prognostication, and precision oncology","volume":"220","author":"Jiang","year":"2026","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ctarc.2026.101454_bib0322","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1016\/j.csbj.2021.06.030","article-title":"Integration strategies of multi-omics data for machine learning analysis","volume":"19","author":"Picard","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101454_bib0323","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nmeth.2810","article-title":"Similarity network fusion for aggregating data types on a genomic scale","volume":"11","author":"Wang","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ctarc.2026.101454_bib0324","article-title":"Lumi-Guide: an artificial-intelligence-driven multimodal framework for optimizing personalized neoadjuvant therapy decision-making in Luminal","volume":"9","author":"Liang","year":"2026","journal-title":"Breast. Cancer Res."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0325","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13073-022-01104-z","article-title":"Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas","volume":"14","author":"Berrino","year":"2022","journal-title":"Genome Med."},{"issue":"13","key":"10.1016\/j.ctarc.2026.101454_bib0326","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.3390\/cancers16132432","article-title":"Decoding the dynamics of circulating tumor DNA in liquid biopsies","volume":"16","author":"Turabi","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0327","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s42234-025-00173-w","article-title":"Revolutionizing breast cancer immunotherapy by integrating AI and nanotechnology approaches: review of current applications and future directions","volume":"11","author":"Bendani","year":"2025","journal-title":"Bioelectron. Med."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101454_bib0328","doi-asserted-by":"crossref","first-page":"731","DOI":"10.4143\/crt.2024.937","article-title":"Machine learning-based prognostic gene signature for early triple-negative breast cancer","volume":"57","author":"Kim","year":"2025","journal-title":"Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0329","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13058-024-01905-7","article-title":"Predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer using a machine learning approach","volume":"26","author":"Zhao","year":"2024","journal-title":"Breast. Cancer Res."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0330","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12859-016-1072-z","article-title":"Joint analysis of histopathology image features and gene expression in breast cancer","volume":"17","author":"Popovici","year":"2016","journal-title":"BMC. Bioinformatics."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0331","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/labinvest.2014.153","article-title":"Novel genotype-phenotype associations in human cancers enabled by advanced molecular platforms and computational analysis of whole slide images","volume":"95","author":"Cooper","year":"2015","journal-title":"Laborat. Investig."},{"issue":"22","key":"10.1016\/j.ctarc.2026.101454_bib0332","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.3390\/cancers16223849","article-title":"Characterization of breast cancer intra-tumor heterogeneity using artificial intelligence","volume":"16","author":"Lashen","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0333","article-title":"Artificial intelligence based quantification of T lymphocyte infiltrate predicts prognosis in high grade breast cancer using deep learning and statistical validation","volume":"16","author":"Albalawi","year":"2025","journal-title":"Discov. Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101454_bib0334","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4048\/jbc.2023.26.e45","article-title":"Artificial intelligence in breast cancer diagnosis and personalized medicine","volume":"26","author":"Ahn","year":"2023","journal-title":"J. Breast. Cancer"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101454_bib0335","first-page":"191","article-title":"Magnetic resonance imaging-based artificial intelligence model predicts neoadjuvant therapy response in triple-negative breast cancer","volume":"32","author":"B\u00fcy\u00fcktoka","year":"2026","journal-title":"Diagn. Interv. Radiol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101454_bib0336","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s10278-013-9622-7","article-title":"The cancer imaging archive (TCIA): maintaining and operating a public information repository","volume":"26","author":"Clark","year":"2013","journal-title":"J. Digit. Imaging"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101454_bib0337","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/amiajnl-2012-001469","article-title":"Cancer digital slide archive: an informatics resource to support integrated in silico analysis of TCGA pathology data","volume":"20","author":"Gutman","year":"2013","journal-title":"J. Am. Med. Inform. Assoc."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0338","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1186\/s12885-023-11638-z","article-title":"Application of CT and MRI images based on an artificial intelligence algorithm for predicting lymph node metastasis in breast cancer patients: a meta-analysis","volume":"23","author":"Liu","year":"2023","journal-title":"BMC. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0339","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-023-11638-z","article-title":"Application of CT and MRI images based on an artificial intelligence algorithm for predicting lymph node metastasis in breast cancer patients: a meta-analysis","volume":"23","author":"Liu","year":"2023","journal-title":"BMC. Cancer"},{"key":"10.1016\/j.ctarc.2026.101454_bib0340","article-title":"Use of artificial intelligence for image analysis in breast cancer screening programmes: systematic review of test accuracy","volume":"374","author":"Freeman","year":"2021","journal-title":"The BMJ"},{"issue":"12","key":"10.1016\/j.ctarc.2026.101454_bib0341","article-title":"Artificial intelligence pipeline for mammography-based breast cancer detection: an integrated systematic review and large-scale experimental validation","volume":"61","author":"A\u00f1ez","year":"2025","journal-title":"Medicina (B Aires)"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101454_bib0342","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100416","article-title":"Artificial intelligence-based mitosis scoring in breast cancer: clinical application","volume":"37","author":"Ibrahim","year":"2024","journal-title":"Mod. Pathol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0343","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3390\/medicina61040581","article-title":"Proposed comprehensive methodology integrated with explainable artificial intelligence for prediction of possible biomarkers in metabolomics panel of plasma samples for breast cancer detection","volume":"61","author":"Colak","year":"2025","journal-title":"Medicina (B Aires)"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101454_bib0344","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100944","article-title":"Agreement across 10 artificial intelligence models in assessing Human epidermal growth factor receptor 2 (HER2) expression in breast cancer whole-slide images","volume":"39","author":"McKelvey","year":"2026","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ctarc.2026.101454_bib0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115394","article-title":"Global disparities in artificial intelligence-based mammogram interpretation for breast cancer: a scientometric analysis of representation, trends, and equity","volume":"220","author":"Miyawaki","year":"2025","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0346","article-title":"Artificial intelligence for breast cancer screening in mammography (AI-STREAM): preliminary analysis of a prospective multicenter cohort study","volume":"16","author":"Chang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ctarc.2026.101454_bib0347","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/bs.acr.2024.06.005","article-title":"Multi-omics based artificial intelligence for cancer research","volume":"163","author":"Li","year":"2024","journal-title":"Adv. Cancer Res."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101454_bib0348","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbag227","article-title":"Toward trustworthy artificial intelligence in multi-omics: a review of reproducibility, stability, and interpretability","volume":"27","author":"Vo","year":"2026","journal-title":"Brief. Bioinform."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101454_bib0349","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ncrna.2022.02.004","article-title":"Long noncoding RNAs as promising biomarkers in cancer","volume":"7","author":"Beylerli","year":"2022","journal-title":"Noncoding. RNa Res."},{"key":"10.1016\/j.ctarc.2026.101454_bib0350","doi-asserted-by":"crossref","DOI":"10.1177\/11772719251381960","article-title":"Extracellular vesicle-derived miRNAs as diagnostic biomarkers for pancreatic ductal adenocarcinoma: a systematic review of methodological rigour and clinical applicability","volume":"20","author":"Patel","year":"2025","journal-title":"Biomark. Insights."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0351","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s43141-021-00174-7","article-title":"Impact of circulating miRNA-373 on breast cancer diagnosis through targeting VEGF and cyclin D1 genes","volume":"19","author":"Bakr","year":"2021","journal-title":"J. Genet. Eng. Biotechnol."},{"issue":"22","key":"10.1016\/j.ctarc.2026.101454_bib0352","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.3390\/cancers15225463","article-title":"The diversity of liquid biopsies and their potential in breast cancer management","volume":"15","author":"Keup","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ctarc.2026.101454_bib0353","doi-asserted-by":"crossref","DOI":"10.1177\/11795549221134831","article-title":"Cancer biomarkers in liquid biopsy for early detection of breast Cancer: a systematic review","volume":"16","author":"Duque","year":"2022","journal-title":"Clin. Med. Insights. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0354","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41523-022-00480-4","article-title":"Multianalyte liquid biopsy to aid the diagnostic workup of breast cancer","volume":"8","author":"Setayesh","year":"2022","journal-title":"NPJ. Breast. Cancer"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101454_bib0355","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/ijc.34337","article-title":"DNA methylation biomarkers for noninvasive detection of triple-negative breast cancer using liquid biopsy","volume":"152","author":"Manoochehri","year":"2023","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101454_bib0356","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaf355","article-title":"A technical review of multi-omics data integration methods: from classical statistical to deep generative approaches","volume":"26","author":"Bai\u00e3o","year":"2025","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.ctarc.2026.101454_bib0357","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.aca.2020.10.038","article-title":"Multi-omics integration in biomedical research - a metabolomics-centric review","volume":"1141","author":"W\u00f6rheide","year":"2021","journal-title":"Anal. Chim. Acta"},{"issue":"1\u20132","key":"10.1016\/j.ctarc.2026.101454_bib0358","article-title":"Computational methods for data integration and imputation of missing values in omics datasets","volume":"25","author":"Schumann","year":"2025","journal-title":"Proteomics"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0359","article-title":"Clinical prediction models using machine learning in oncology: challenges and recommendations","volume":"4","author":"Collins","year":"2025","journal-title":"BMJ Oncol"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101454_bib0360","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41571-024-00909-8","article-title":"Towards equitable AI in oncology","volume":"21","author":"Viswanathan","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101454_bib0361","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1038\/s41588-026-02663-2","article-title":"Mapping the path to clinical implementation of multi-omics","volume":"58","author":"Ismail","year":"2026","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ctarc.2026.101454_bib0362","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101454_bib0363","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.72452","article-title":"Multi-omics biomarkers from variant to clinic: a systematic review and meta-analysis of evidence, AI\/ML, governance, equity, and real-world implementation across global health systems","volume":"9","author":"Das","year":"2026","journal-title":"Health Sci. Rep."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0364","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48570-x","article-title":"Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series","volume":"9","author":"Vallon-Christersson","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101454_bib0365","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s43556-025-00340-0","article-title":"Multi-omics strategies for biomarker discovery and application in personalized oncology","volume":"6","author":"Jiang","year":"2025","journal-title":"Mol. Biomed."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:47:37Z","timestamp":1791488857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226003643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":365,"alternative-id":["S2468294226003643"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101454","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-omics and molecular biomarkers in breast cancer: a comprehensive review of diagnostic, prognostic, and predictive applications","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101454","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101454"}}